社区高血压患者降压药物依从性研究进展

Study on medication compliance in patients with hypertension in community

高血压是一种心血管综合征,近年来发病率一直居高不下,治愈率不高,会增加患者其他心脑血管疾病的风险,给患者带来更大的危害,有较高的致残致死率。服药依从性差是我国广大社区高血压患者常见的问题,也是影响其治疗效果的重要因素,对其影响因素进行分析,不仅能够丰富现有研究内容,也能够为针对性解决措施的提出提供科学依据。近年来人们对社区高血压患者降压药物依从性的研究已经有了一定的进展,为了改善依从性,防止疾病的发展和并发症的发生,提高患者生活质量,降低致残率、致死率,本文根据我国高血压防治指南中规定5类降压药(β受体阻滞剂、ACEI、ARB、CCB、利尿剂)分别阐述其研究进展。

Hypertension is a kind of cardiovascular syndrome,with high incidence and low cure rate in recent years. It will increase the risk of other heart cerebrovascular disease and bring greater harm to the patients,with the higher morbidity and mortality. Poor medication compliance is the common problem of hypertension patients in community of our country,it is also an important factor affecting its therapeutic effect,and to analyze its influence factors,can not only enriched the contents of the existing research,but also provide scientific basis for targeted solution. In recent years,there has been some progress in the study of medication compliance of antihypertensive drug in patients with hypertension in community. In order to improve compliance,prevent the development of the disease and the occurrence of complications,improve the quality of patients＇ life, reduce morbidity and mortality, the research progress of 5 kinds of antihypertensive drugs（beta blockers,ACEI,ARB,CCB,diuretics）according to the Chinese guidelines for prevention and treatment of hypertension were reviewed in this paper.